{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:23:20Z","timestamp":1790648600297,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03863-4","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:28:45Z","timestamp":1753435725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of micro-, meso-, and macro-level stigma on the uptake of medications for opioid use disorder (MOUD) among women in the criminal legal system"],"prefix":"10.1186","volume":"25","author":[{"given":"Oluwaseyi Halimat","family":"Quadri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Skogseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abenaa A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"3863_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/ADM.0000000000000622","volume":"14","author":"SA Springer","year":"2020","unstructured":"Springer SA, Biondi BE, Frank C, El-Bassel N. A call to action to combat the opioid epidemic among women. J Addict Med. 2020;14:364\u20136. https:\/\/doi.org\/10.1097\/ADM.0000000000000622.","journal-title":"J Addict Med"},{"key":"3863_CR2","doi-asserted-by":"publisher","first-page":"174550572413070","DOI":"10.1177\/17455057241307088","volume":"20","author":"AA Jones","year":"2024","unstructured":"Jones AA, Segel JE, Skogseth EM, Apsley HB, Santos-Lozada AR. Drug overdose deaths among women 1999\u20132021 in the united states: differences by race, ethnicity, and age. Womens Health. 2024;20:17455057241307088. https:\/\/doi.org\/10.1177\/17455057241307088.","journal-title":"Womens Health"},{"issue":"3","key":"3863_CR3","doi-asserted-by":"publisher","first-page":"e251158","DOI":"10.1001\/jamanetworkopen.2025.1158","volume":"8","author":"AH Kral","year":"2025","unstructured":"Kral AH, Humphrey JL, Schwab C, Lambdin BH, Ray B. Law enforcement drug seizures and opioid-involved overdose mortality. JAMA Netw Open. 2025;8(3):e251158. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.1158.","journal-title":"JAMA Netw Open"},{"key":"3863_CR4","doi-asserted-by":"publisher","first-page":"109427","DOI":"10.1016\/j.drugalcdep.2022.109427","volume":"235","author":"A Larnder","year":"2022","unstructured":"Larnder A, Saatchi A, Borden SA, Moa B, Gill CG, Wallace B, Hore D. Variability in the unregulated opioid market in the context of extreme rates of overdose. Drug Alcohol Depend. 2022;235:109427. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109427.","journal-title":"Drug Alcohol Depend"},{"key":"3863_CR5","doi-asserted-by":"publisher","first-page":"209051","DOI":"10.1016\/j.josat.2023.209051","volume":"149","author":"MD Booty","year":"2023","unstructured":"Booty MD, Harp K, Batty E, Knudsen HK, Staton M, Oser CB. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: perspectives from clinicians. J Subst Use Addict Treat. 2023;149:209051. https:\/\/doi.org\/10.1016\/j.josat.2023.209051.","journal-title":"J Subst Use Addict Treat"},{"key":"3863_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1176\/appi.ajp.20230918","volume":"181","author":"JD Ellis","year":"2024","unstructured":"Ellis JD, Dunn KE, Huhn AS. Harm reduction for opioid use disorder: strategies and outcome metrics. Am J Psychiatry. 2024;181:372\u201380. https:\/\/doi.org\/10.1176\/appi.ajp.20230918.","journal-title":"Am J Psychiatry"},{"key":"3863_CR7","doi-asserted-by":"publisher","unstructured":"Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Green Montaque HD. You\u2019re not supposed to be on it forever: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Subst Abuse. 2022;16. https:\/\/doi.org\/10.1177\/11782218221103859.","DOI":"10.1177\/11782218221103859"},{"issue":"2","key":"3863_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/00220426231204841","volume":"55","author":"M Hutchison","year":"2023","unstructured":"Hutchison M, Russell BS, Leander A, Rickles N, Aguiar D, Cong XS, Harel O, Hernandez AV. Trends and barriers of medication treatment for opioid use disorders: a systematic review and meta-analysis. J Drug Issues. 2023;55(2):193\u2013214. https:\/\/doi.org\/10.1177\/00220426231204841.","journal-title":"J Drug Issues"},{"issue":"2","key":"3863_CR9","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1080\/10826084.2017.1363238","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622. https:\/\/doi.org\/10.1080\/10826084.2017.1363238.","journal-title":"JAMA Netw Open"},{"key":"3863_CR10","doi-asserted-by":"publisher","first-page":"100056","DOI":"10.1016\/j.dadr.2022.10005611","volume":"3","author":"KE Moore","year":"2022","unstructured":"Moore KE, Siebert SL, Kromash R, Owens MD, Allen DC. Negative attitudes about medications for opioid use disorder among criminal legal staff. Drug Alcohol Depend Rep. 2022;3:100056. https:\/\/doi.org\/10.1016\/j.dadr.2022.10005611.","journal-title":"Drug Alcohol Depend Rep"},{"key":"3863_CR11","doi-asserted-by":"publisher","first-page":"209270","DOI":"10.1016\/j.josat.2023.209270","volume":"159","author":"K McLean","year":"2024","unstructured":"McLean K, Murphy J, Kruis N. I think we\u2019re getting better but we\u2019re still not there: Provider-based stigma and perceived barriers to care for people who use opioids (PWUO). J Subst Use Addict Treat. 2024;159:209270. https:\/\/doi.org\/10.1016\/j.josat.2023.209270.","journal-title":"J Subst Use Addict Treat"},{"key":"3863_CR12","unstructured":"Department of Justice US. DEA. A-23-0020-Dear-Registrant-Letter-Signed. US Dep Justice Drug Enforc Adm. 2023.Available from: https:\/\/www.deadiversion.usdoj.gov\/pubs\/docs\/A-23-0020-Dear-Registrant-Letter-Signed.pdf"},{"key":"3863_CR13","unstructured":"SAMHSA. Evidence-based resource guide series use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings. SAMHSA. 2019. Available from: https:\/\/store.samhsa.gov\/sites\/default\/files\/treatment-criminal-justice-pep19-matusecjs.pdf"},{"key":"3863_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/SAR.S409944","volume":"14","author":"M Staton","year":"2023","unstructured":"Staton M, Tillson M, Levi M, Dickson M, Webster M, Leukefeld C. Identifying and treating incarcerated women experiencing substance use disorders: A review. Subst Abuse Rehabil. 2023;14:131\u201345. https:\/\/doi.org\/10.2147\/SAR.S409944.","journal-title":"Subst Abuse Rehabil"},{"key":"3863_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","volume":"99","author":"KE Moore","year":"2019","unstructured":"Moore KE, Roberts W, Reid HH, Smith KMZ, Oberleitner LMS, McKee SA. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review. J Subst Abuse Treat. 2019;99:32\u201343. https:\/\/doi.org\/10.1016\/j.jsat.2018.12.003.","journal-title":"J Subst Abuse Treat"},{"key":"3863_CR16","doi-asserted-by":"publisher","unstructured":"Schwartz R, Sharma A, O\u2019Grady K, Kelly S, Gryczynski J, Mitchell S. Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst Abuse Rehabil. 2016;27. https:\/\/doi.org\/10.2147\/sar.s81602.","DOI":"10.2147\/sar.s81602"},{"issue":"25","key":"3863_CR17","first-page":"11","volume":"56","author":"E Goffman","year":"1963","unstructured":"Goffman E, Stigma. Notes on the management of a spoiled identitiy. Am J Sociol. 1963;56(25):11.","journal-title":"Am J Sociol"},{"issue":"3","key":"3863_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jnu.12837","volume":"55","author":"MK McCurry","year":"2023","unstructured":"McCurry MK, Avery-Desmarais S, Schuler M, Tyo M, Viveiros J, Kauranen B. Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare. J Nurs Scholarsh. 2023;55(3):701\u201310. https:\/\/doi.org\/10.1111\/jnu.12837.","journal-title":"J Nurs Scholarsh"},{"key":"3863_CR19","doi-asserted-by":"publisher","unstructured":"Cheetham A, Picco L, Barnett A, Lubman DI, Nielsen S. The impact of stigma on people with opioid use disorder, opioid treatment, and policy. Subst Abuse Rehabil 2022; Volume 13:1\u201312. https:\/\/doi.org\/10.2147\/SAR.S304566","DOI":"10.2147\/SAR.S304566"},{"key":"3863_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.drugalcdep.2017.12.037","volume":"185","author":"K Goodyear","year":"2018","unstructured":"Goodyear K, Haass-Koffler CL, Chavanne D. Opioid use and stigma: the role of gender, Language and precipitating events. Drug Alcohol Depend. 2018;185:339\u201346. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.12.037.","journal-title":"Drug Alcohol Depend"},{"key":"3863_CR21","doi-asserted-by":"publisher","unstructured":"Syvertsen JL, Toneff H, Howard H, Spadola C, Madden D, Clapp J. Conceptualizing stigma in contexts of pregnancy and opioid misuse: A qualitative study with women and healthcare providers in Ohio. Drug Alcohol Depend. 2021;222. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.10867722.","DOI":"10.1016\/j.drugalcdep.2021.10867722"},{"issue":"6","key":"3863_CR22","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1007\/s11469-022-00768-3","volume":"20","author":"JL Chou","year":"2022","unstructured":"Chou JL, Patton R, Cooper-Sadlo S, Swan C, Bennett DS, McDowell D, et al. Stigma and medication for opioid use disorder (MOUD) among women. Int J Ment Health Addict. 2022;20(6):3262\u201373. https:\/\/doi.org\/10.1007\/s11469-022-00768-3.","journal-title":"Int J Ment Health Addict"},{"issue":"6","key":"3863_CR23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s10461-013-0649-z","volume":"18","author":"P Chi","year":"2014","unstructured":"Chi P, Li X, Zhao J, Zhao G. Vicious circle of perceived stigma, enacted stigma and depressive symptoms among children affected by HIV\/AIDS in China. AIDS Behav. 2014;18(6):1054\u201362. https:\/\/doi.org\/10.1007\/s10461-013-0649-z.","journal-title":"AIDS Behav"},{"issue":"8","key":"3863_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.socscimed.2008.05.032","volume":"67","author":"WT Steward","year":"2008","unstructured":"Steward WT, Herek GM, Ramakrishna J, Bharat S, Chandy S, Wrubel J, et al. HIV-related stigma: adapting a theoretical framework for use in India. Soc Sci Med. 2008;67(8):1225\u201335. https:\/\/doi.org\/10.1016\/j.socscimed.2008.05.032.","journal-title":"Soc Sci Med"},{"key":"3863_CR25","doi-asserted-by":"publisher","unstructured":"Anvari MS, Kleinman MB, Massey EC, Bradley VD, Felton JW, Belcher AM, et al. In their mind, they always felt less than: the role of peers in shifting stigma as a barrier to opioid use disorder treatment retention. J Subst Abuse Treat. 2022;138. https:\/\/doi.org\/10.1016\/j.jsat.2022.108721.","DOI":"10.1016\/j.jsat.2022.108721"},{"key":"3863_CR26","doi-asserted-by":"publisher","unstructured":"Hewell VM, Vasquez AR, Rivkin ID. Systemic and individual factors in the buprenorphine treatment-seeking process: A qualitative study. Subst Abuse Treat Prev Policy. 2017;12(1). https:\/\/doi.org\/10.1186\/s13011-016-0085-y.","DOI":"10.1186\/s13011-016-0085-y"},{"issue":"4","key":"3863_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/1473325016680282","volume":"17","author":"AJ Gunn","year":"2018","unstructured":"Gunn AJ, Sacks TK, Jemal A. That\u2019s not me anymore: resistance strategies for managing intersectional stigmas for women with substance use and incarceration histories. Qualitative Social Work. 2018;17(4):490\u2013508. https:\/\/doi.org\/10.1177\/1473325016680282.","journal-title":"Qualitative Social Work"},{"key":"3863_CR28","doi-asserted-by":"publisher","unstructured":"Fiddian-Green A, Gubrium A, Harrington C, Evans EA. Women-reported barriers and facilitators of continued engagement with medications for opioid use disorder. Int J Environ Res Public Health. 2022;19(15). https:\/\/doi.org\/10.3390\/ijerph19159346.","DOI":"10.3390\/ijerph19159346"},{"key":"3863_CR29","doi-asserted-by":"publisher","first-page":"109715","DOI":"10.1016\/j.drugalcdep.2022.109715","volume":"242","author":"HB Apsley","year":"2023","unstructured":"Apsley HB, Brant K, Brothers S, Harrison E, Skogseth, E., Schwartz RP, & Jones AA. Pregnancy-and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them. Women's Health. 2024;20:17455057231224181.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3863_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1176\/appi.prcp.20190051","volume":"3","author":"C Barbosa-Leiker","year":"2021","unstructured":"Barbosa-Leiker C, Campbell ANC, McHugh RK, Guille C, Greenfield SF. Opioid use disorder in women and the implications for treatment. Psychiatric Res Clin Pract. 2021;3(1):3\u201311. https:\/\/doi.org\/10.1176\/appi.prcp.20190051.","journal-title":"Psychiatric Res Clin Pract"},{"issue":"1","key":"3863_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/08897077.2021.1944954","volume":"43","author":"CE Martin","year":"2022","unstructured":"Martin CE, Almeida T, Thakkar B, Kimbrough T. Postpartum and addiction recovery of women in opioid use disorder treatment: A qualitative study. Substance Abuse. 2022;43(1):389\u201396.","journal-title":"Substance Abuse"},{"key":"3863_CR32","unstructured":"Substance Abuse and Mental Health Services Administration. The opioid crisis and the Black\/African American population: An urgent issue [Internet]. 2020. Available from: https:\/\/store.samhsa.gov\/sites\/default\/files\/pep20-05-02-001.pdf"},{"issue":"1","key":"3863_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10995-022-03526-y","volume":"27","author":"C Kramer","year":"2023","unstructured":"Kramer C, Thomas K, Patil A, Hayes CM, Sufrin CB. Shackling and pregnancy care policies in US prisons and jails. Matern Child Health J. 2023;27(1):186\u201396. https:\/\/doi.org\/10.1007\/s10995-022-03526-y.","journal-title":"Matern Child Health J"},{"key":"3863_CR34","doi-asserted-by":"publisher","unstructured":"Strong-Jones S, Brant K, Kreager D, Harrison E, Jones A. Adverse effects of criminal legal system involvement: A qualitative study examining the role of incarceration and reentry on substance use trajectories among women with opioid use disorders. BMC Glob Public Health. 2024;2(1). https:\/\/doi.org\/10.1186\/s44263-024-00058-1.","DOI":"10.1186\/s44263-024-00058-1"},{"key":"3863_CR35","doi-asserted-by":"publisher","unstructured":"Skogseth EM, Brant K, Harrison E, Apsley HB, Crowley M, Schwartz RP, et al. Women and treatment for opioid use disorder: contributors to treatment success from the perspectives of women in recovery, women with past attempts in drug treatment, and health and criminal justice professionals. Subst Use Res Treat. 2024;18. https:\/\/doi.org\/10.1177\/11782218231222339.","DOI":"10.1177\/11782218231222339"},{"key":"3863_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jsat.2019.04.008","volume":"102","author":"B Bearnot","year":"2019","unstructured":"Bearnot B, Mitton JA, Hayden M, Park ER. Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: results from a qualitative study. J Subst Abuse Treat. 2019;102:16\u201322. https:\/\/doi.org\/10.1016\/j.jsat.2019.04.008.","journal-title":"J Subst Abuse Treat"},{"key":"3863_CR37","doi-asserted-by":"publisher","first-page":"209270","DOI":"10.1016\/j.josat.2023.209270","volume":"159","author":"K McLean","year":"2024","unstructured":"McLean K, Murphy J, Kruis N. I think we\u2019re getting better but we\u2019re still not there: Provider-based stigma and perceived barriers to care for people who use opioids (PWUO). J Subst Use Addict Treat. 2024;159:209270. https:\/\/doi.org\/10.1016\/j.josat.2023.209270. Epub 2023 Dec 14. PMID:.","journal-title":"J Subst Use Addict Treat"},{"key":"3863_CR38","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.dadr.2023.100138","volume":"6","author":"A Carl","year":"2023","unstructured":"Carl A, Pasman E, Broman MJ, Lister JJ, Agius E, Resko SM. Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone. Drug Alcohol Depend Rep. 2023;6:100138. https:\/\/doi.org\/10.1016\/j.dadr.2023.100138.","journal-title":"Drug Alcohol Depend Rep"},{"key":"3863_CR39","doi-asserted-by":"publisher","unstructured":"Grella CE, Ostile E, Scott CK, Dennis M, Carnavale J. A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. Int J Drug Policy. 2020;81. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102768.","DOI":"10.1016\/j.drugpo.2020.102768"},{"issue":"3","key":"3863_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.socscimed.2008.03.018","volume":"67","author":"BA Pescosolido","year":"2008","unstructured":"Pescosolido BA, Martin JK, Lang A, Olafsdottir S. Rethinking theoretical approaches to stigma: A framework integrating normative influences on stigma (FINIS). Soc Sci Med. 2008;67(3):431\u201340. https:\/\/doi.org\/10.1016\/j.socscimed.2008.03.018.","journal-title":"Soc Sci Med"},{"issue":"8","key":"3863_CR41","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1037\/adb0001007","volume":"38","author":"AA Jones","year":"2024","unstructured":"Jones AA, Strong-Jones S, Bishop RE, Brant K, Owczarzak J, Ngigi KW, Latkin C. The impact of family systems and social networks on substance use initiation and recovery among women with substance use disorders. Psychol Addict Behav. 2024;38(8):850\u20139. https:\/\/doi.org\/10.1037\/adb0001007. Epub 2024 Apr 25. PMID: 38661657; PMCID: PMC11502511.","journal-title":"Psychol Addict Behav"},{"key":"3863_CR42","doi-asserted-by":"publisher","first-page":"209587","DOI":"10.1016\/j.josat.2024.209587","volume":"169","author":"AA Jones","year":"2025","unstructured":"Jones AA, Brant K, Bishop RE, Strong-Jones S, Kreager DA. Just an unfair score: perceptions of gender inequity in the treatment of substance use disorders among women involved in the criminal legal system. J Subst Use Addict Treat. 2025;169:209587. https:\/\/doi.org\/10.1016\/j.josat.2024.209587.","journal-title":"J Subst Use Addict Treat"},{"key":"3863_CR43","doi-asserted-by":"publisher","unstructured":"Couch JV, Whitcomb M, Buchheit BM, Dorr DA, Malinoski DJ, Korthuis PT et al. Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis. Harm Reduct J [Internet].2024; 21(1):125. Available from: https:\/\/doi.org\/10.1186\/s12954-024-01043-5","DOI":"10.1186\/s12954-024-01043-5"},{"key":"3863_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/sar.s183256","volume":"9","author":"RA Hammarlund","year":"2018","unstructured":"Hammarlund RA, Crapanzano KA, Luce L, Mulligan LA, Ward KM. Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders. Subst Abuse Rehabil. 2018;9:115\u201336. https:\/\/doi.org\/10.2147\/sar.s183256.","journal-title":"Subst Abuse Rehabil"},{"key":"3863_CR45","doi-asserted-by":"publisher","unstructured":"Eddie D, Hoffman L, Vilsaint C, Abry A, Bergman B, Hoeppner B, et al. Lived experience in new models of care for substance use disorder: A systematic review of peer recovery support services and recovery coaching. Front Psychol. 2019;10. https:\/\/doi.org\/10.3389\/fpsyg.2019.01052.","DOI":"10.3389\/fpsyg.2019.01052"},{"issue":"14","key":"3863_CR46","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1080\/10826084.2021.1975749","volume":"56","author":"EF Madden","year":"2021","unstructured":"Madden EF, Prevedel S, Light T, Sulzer SH. Intervention stigma toward medications for opioid use disorder: A systematic review. Subst Use Misuse. 2021;56(14):2181\u2013201. https:\/\/doi.org\/10.1080\/10826084.2021.1975749.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"3863_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res. 2017;27(4):591\u2013608. https:\/\/doi.org\/10.1177\/1049732316665344. Epub 2016 Sep 26. PMID: 27670770; PMCID: PMC9359070.","journal-title":"Qual Health Res"},{"key":"3863_CR48","unstructured":"Abner A, Bellos SB, Rojo S, Su R, Yeh M, Morgan-Kurtz A. Medication for opioid use disorder in Pennsylvania jails and prisons. 2022."},{"key":"3863_CR49","unstructured":"Bleiberg BS, Ming YJ, Brown-Sadler B, Bowens K, Leiferman K, Kim S. Medication for opioid use disorder in Pennsylvania jails and prisons: a report by the Pennsylvania Institutional Law Project.2024. https:\/\/pilp.org\/moud"},{"issue":"9","key":"3863_CR50","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1037\/amp0000744","volume":"75","author":"VA Earnshaw","year":"2020","unstructured":"Earnshaw VA. Stigma and substance use disorders: A clinical, research, and advocacy agenda. Am Psychol. 2020;75(9):1300\u201311. https:\/\/doi.org\/10.1037\/amp0000744.","journal-title":"Am Psychol"},{"key":"3863_CR51","doi-asserted-by":"publisher","unstructured":"Frank D. The trouble with morality: the effects of 12-step discourse on addicts\u2019 decision-making. J Psychoact Drugs. 2011 Jul-Sep;43(3):245\u201356. https:\/\/doi.org\/10.1080\/02791072.2011.605706. PMID: 22111408; PMCID: PMC4788510.","DOI":"10.1080\/02791072.2011.605706"},{"key":"3863_CR52","doi-asserted-by":"crossref","unstructured":"McCracken A, Brant K, Latkin C, Jones A. Tethered to this ball and chain: women\u2019s perspectives on bodily agency within opioid treatment programs. Int J Drug Policy. 2024 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0955395924003293","DOI":"10.1016\/j.drugpo.2024.104645"},{"key":"3863_CR53","volume-title":"Access to medications for opioid use disorder and harm reduction services across rural Pennsylvania","author":"K Brant","year":"2025","unstructured":"Brant K, McCracken A. Access to medications for opioid use disorder and harm reduction services across rural Pennsylvania. Rural Policy: The Research Bulletin of the Center for Rural Pennsylvania; 2025."},{"key":"3863_CR54","doi-asserted-by":"publisher","DOI":"10.1037\/sah0000510","author":"VA Earnshaw","year":"2024","unstructured":"Earnshaw VA, Brousseau NM, Hill EC, Laurenceau JP, Sepucha KR, Qiu X, et al. Enacted stigma from family and drug use during opioid use disorder treatment. Stigma Health. 2024. https:\/\/doi.org\/10.1037\/sah0000510.","journal-title":"Stigma Health"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03863-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:14:19Z","timestamp":1757286859000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03863-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3863"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03863-4","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Pennsylvania State University Institutional Review Board (STUDY00018974) and conducted in accordance with the ethical principles outlined in the Belmont Report\u2212respect for persons, beneficence, and justice\u2212as well as broader standards set by institutional and national research committees. Informed consent was obtained from all participants. After the participant provided verbal consent to participate in the study and have the interview recorded, the right to withdraw at any point during the interview was respected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"To provide transparency and context for the reader, we wish to share information about our backgrounds. At the time this manuscript was drafted, all authors self-identified as women. In terms of racial identity, two of the authors identified as white, one as African American, and one as African, with the corresponding author being from Nigeria in Sub-Saharan Africa. Be mindful that our identities, including our lived experiences, can influence the way we approach the topic of opioid use disorder and stigma (Roberts et al., 2020). As women and scholars from diverse racial and geographic backgrounds, we bring different perspectives to this work, which we believe enriches our understanding of the experiences of women in the criminal legal system. However, we also recognize that our perspectives are limited and shaped by our specific contexts, and we are mindful of how these might impact our analysis and interpretation of the stigma surrounding medications for opioid use disorder.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author information"}}],"article-number":"370"}}